CTOs on the Move


 
FocusOne is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Osseon Therapeutics

Osseon Therapeutics is a Santa Rosa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GI Alliance

At the core, GI Alliance operates on a philosophy grounded by three guiding principles: Patient First. Quality Centric. Provider-Led. Our strength comes from the diversity of talented individuals who make up our organization—everyone striving to serve our patients with excellence every day. We have designed our practice to foster and develop a diverse culture, both clinical and non-clinical. It is not merely words for our practice. Our company values and celebrates the diversity of our physicians, staff and patients. We firmly believe our service is greatly enriched by our diversity of thought, experience, perspective, culture and background. The people of GI Alliance are the best in the industry, and that results in a great working environment.

Simulation and Training Environment Laboratory

Simulation and Training Environment Laboratory is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.

Satellite Healthcare

Making Life Better for Those Living with Kidney Disease. For nearly 40 years, our mission has remained unchanged. From the patient chair side to the boardroom, this powerful yet practical principle guides our daily clinical work as well as our leadership decisions.